ICoronavirus, iCovid-19 Vaccine Covaxin Uhlaziyo lwamva nje: I-Covaxin yeBharat Biotech

I-Covid 19

I-Bharat Biotech's Covaxin sisitofu sokugonya esingasetyenziswayo ngokuchasene ne-COVID-19 esithe saphuhliswa eIndiya. Nalu olunye uhlaziyo lwamva nje lweCovaxin:

  • Ukusebenza: Kwidatha yolingo lwethutyana lwezonyango, i-Covaxin ibonakaliswe inezinga lokusebenza ngama-77.8% ngokuchasene neempawu ze-COVID-19. Isitofu sokugonya sikwabonakaliswe ukuba sisebenza ngama-93.4% kwiimeko ezimandundu ze-COVID-19.
  • Ukuvunywa: I-Covaxin yamkelwe ukuba isetyenziswe ngokungxamisekileyo nguMbutho wezeMpilo weHlabathi (i-WHO), kwaye yamkelwe ukuba isetyenziswe eIndiya nakwamanye amazwe amaninzi.
  • Idosi yokukhuthaza: I-Bharat Biotech inike ingxelo yokuba idosi ye-booster ye-Covaxin ibonakaliswe ukuba yonyusa amanqanaba e-antibody kakhulu, kwaye inkampani iceba ukuqhuba ulingo lwezonyango lwesigaba sesi-3 ukuvavanya ukhuseleko kunye nokusebenza kwedosi yesithathu yesitofu sokugonya.
  • umthamo Production: I-Bharat Biotech iye yanyusa umthamo wayo wemveliso ye-Covaxin, ngenjongo yokuvelisa idosi yebhiliyoni yesitofu sogonyo ngonyaka. Inkampani ikwatyikitye izivumelwano namanye amazwe aliqela ukubonelela ngeCovaxin.
  • Ezahlukeneyo: I-Bharat Biotech inike ingxelo yokuba i-Covaxin iyasebenza ngokuchasene ne-Delta eyahlukileyo yentsholongwane, eyona nto ixhalabisayo ngoku kwihlabathi jikelele.

Ngokubanzi, i-Covaxin ibonise iziphumo ezithembisayo kulingo lwezonyango kwaye yamkelwe ukuba isetyenziswe ngokungxamisekileyo kumazwe aliqela.